Does LivaNova PLC (NASDAQ:LIVN) Look Expensive At $64.15? Here’s How To Know.
In last trading session, LivaNova PLC (NASDAQ:LIVN) saw 0.89 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level
In last trading session, LivaNova PLC (NASDAQ:LIVN) saw 0.89 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level
In last trading session, Turnstone Biologics Corp (NASDAQ:TSBX) saw 0.36 million shares changing hands with its beta currently measuring 0. Company’s recent per share price
In last trading session, Enviva Inc (NYSE:EVA) saw 0.68 million shares changing hands with its beta currently measuring 0.82. Company’s recent per share price level
In last trading session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) saw 0.67 million shares changing hands with its beta currently measuring 2.68. Company’s recent per share
In last trading session, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) saw 0.37 million shares changing hands with its beta currently measuring 0.66. Company’s recent per share price
In last trading session, Calidi Biotherapeutics Inc (AMEX:CLDI) saw 0.49 million shares changing hands with its beta currently measuring 0.57. Company’s recent per share price
In last trading session, American Resources Corporation (NASDAQ:AREC) saw 0.4 million shares changing hands with its beta currently measuring 0.35. Company’s recent per share price
In last trading session, Bitdeer Technologies Holding Co (NASDAQ:BTDR) saw 0.5 million shares changing hands with its beta currently measuring 1.78. Company’s recent per share
In last trading session, Axogen Inc. (NASDAQ:AXGN) saw 0.31 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level
In last trading session, Elevation Oncology Inc (NASDAQ:ELEV) saw 0.43 million shares changing hands with its beta currently measuring 1.54. Company’s recent per share price
© 2024, Powered by Smart TechOne